Policy Outlook: Reviewing the Pathway for Advancing Biopharma Goals in Congress and the White House

2:00 PM - 3:00 PM (EST), Wednesday, February 17, 2021
With the arrival of a new administration and the potential for a new Congress, access to medicines and advancing innovation remain key goals for the industry. Discussion on COVID-19 vaccines and therapeutics, drug pricing policy, and regulatory guidance including PDUFA VII are of interest in the policy landscape. Hear the latest perspective from experts within the Beltway and company executives to prepare for the next four years.
Moderator
photo
Managing Director
Deloitte Consulting LLP
Speakers
photo
Managing Director
Deloitte Consulting LLP
photo
Vice President, Infectious Diseases and Diagnostics Policy
Biotechnology Innovation Organization
photo
Partner
Tarplin, Downs & Young LLC
photo
Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy
Merck
photo
Chairman & CEO
Alkermes, Inc.